AME’s 2022 profits grow 26% to SAR 26.7 mln

AME’s 2022 profits grow 26% to SAR 26.7 mln

22/03/2023 Argaam Exclusive

View other reports

AME Company for Medical Supplies posted a 26% rise in 2022 net profit to SAR 26.7 million, from SAR 21.2 million a year earlier.



Financials (M)

Item 2021 2022 Change‬
Revenues 151.39 193.17 27.6 %
Gross Income 69.55 90.28 29.8 %
Operating Income 28.96 29.98 3.5 %
Net Income 21.22 26.68 25.7 %
Average Shares 7.00 7.00 -
EPS (Riyals) 3.03 3.81 25.7 %

The profit growth was driven by an increase of SAR 41.78 million year-on-year (YoY) in net revenue for 2022 (net sales proceeds), as well as a rise of SAR 33.8 million and SAR 8 million in the sales of in medical supplies and devices, respectively.

 

This surge resulted from the company’s acquisition of a larger market share thanks to its participation in local and international conferences, along with more effort to advertise and market its products.

 



Total shareholders’ equity, no minority interest, rose to SAR 107.3 million as of Dec. 31, 2022, compared to SAR 93.4 million in the year-earlier period.

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2013 - - - - - - -
Q2 2013 - - - - - - -
Q3 2013 - - - - - - -
Q4 2013 - - - - - - -
Q1 2014 - - - - - - -
Q2 2014 - - - - - - -
Q3 2014 - - - - - - -
Q4 2014 - - - - - - -
Q1 2015 - - - - - - -
Q2 2015 - - - - - - -
Q3 2015 - - - - - - -
Q4 2015 - - - - - - -
Q1 2016 - - - - - - -
Q2 2016 - - - - - - -
Q3 2016 - - - - - - -
Q4 2016 - - - - - - -
Q1 2017 - - - - - - -
Q2 2017 - - - - - - -
Q3 2017 - - - - - - -
Q4 2017 - - - - - - -
Q1 2018 - - - - - - -
Q2 2018 - - - - - - -
Q3 2018 - - - - - - -
Q4 2018 - - - - - - -
Q1 2019 - - - - - - -
Q2 2019 - - - - - - -
Q3 2019 - - - - - - -
Q4 2019 - - - - - - -
Q1 2020 31.44 - 15.42 - 3.36 - 0.48
Q2 2020 - - - - - - -
Q3 2020 - - - - - - -
Q4 2020 - - - - - - -
Q1 2021 32.16 2.3 % 15.17 (1.6 %) 5.58 65.9 % 0.80
Q2 2021 37.62 - 16.83 - 1.92 - 0.27
Q3 2021 - - - - - - -
Q4 2021 - - - - - - -
Q1 2022 54.29 68.8 % 22.22 46.5 % 5.87 5.3 % 0.84
Q2 2022 54.06 43.7 % 26.64 58.3 % 9.51 395.1 % 1.36
Q3 2022 - - - - - - -
Q4 2022 - - - - - - -
2022 193.17 27.6 % 90.28 29.8 % 26.68 25.7 % 3.81

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 49.05 % - 10.69 %
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 48.10 % - 14.06 %
Q2 2021 46.85 % - 15.00 %
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 44.78 % - 13.54 %
Q2 2022 45.39 % - 15.27 %
Q3 2022 - - -
Q4 2022 - - -
2022 46.74 % 15.96 % 13.81 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 7.00 0.48 0.48 -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 7.00 1.28 1.28 -
Q2 2021 7.00 1.55 2.17 11.72
Q3 2021 - - - -
Q4 2021 - - - -
Q1 2022 7.00 2.39 3.01 -
Q2 2022 7.00 3.27 3.89 13.79
Q3 2022 - - - -
Q4 2022 - - - -

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 23.43 18.62 -
Q2 2022 13.31 11.20 3.15
Q3 2022 - - -
Q4 2022 - - -

Business Segments (Million)

Compared With The
Period Medical supplies medical tools Maintenance & Management sector Others


Financial Ratios
Current
Market Cap (M Riyal) 413.00
Enterprise Value (EV) (M) 369.60
Shares Outstanding ((M)) 7.00
Book Value (BV) ( Riyal) 18.17
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 12.32
Price/book 3.25
more

Share Price

AME Company for Medical Supplies
59.40
(0.10) (0.17 %)

AME Company for Medical Supplies (AME)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.